BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30017269)

  • 1. The interobserver agreement in the detection of recurrent HNSCC using MRI including diffusion weighted MRI.
    Peltenburg B; Driessen JP; Philippens MEP; Pameijer FA; Castelijns J; Dankbaar JW; Dorgelo B; Lange CAH; Meijer FJA; Palm WM; Roosendaal SD; Steens SCA; Verbist BM; Stegeman I; Janssen LM; de Bree R; Terhaard CHJ
    Eur J Radiol; 2018 Aug; 105():134-140. PubMed ID: 30017269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
    Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
    Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
    Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers.
    Tshering Vogel DW; Zbaeren P; Geretschlaeger A; Vermathen P; De Keyzer F; Thoeny HC
    Eur Radiol; 2013 Feb; 23(2):562-9. PubMed ID: 22865270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective comparative study of MRI including diffusion-weighted images versus FDG PET-CT for the detection of recurrent head and neck squamous cell carcinomas after (chemo)radiotherapy.
    Driessen JP; Peltenburg B; Philippens MEP; Huijbregts JE; Pameijer FA; de Bree R; Janssen LM; Terhaard CHJ
    Eur J Radiol; 2019 Feb; 111():62-67. PubMed ID: 30691667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings.
    Vandecaveye V; De Keyzer F; Nuyts S; Deraedt K; Dirix P; Hamaekers P; Vander Poorten V; Delaere P; Hermans R
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):960-71. PubMed ID: 17141979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
    Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
    Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
    Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
    Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.
    Dirix P; Vandecaveye V; De Keyzer F; Op de Beeck K; Poorten VV; Delaere P; Verbeken E; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):761-6. PubMed ID: 19540069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma.
    Lambrecht M; Van Calster B; Vandecaveye V; De Keyzer F; Roebben I; Hermans R; Nuyts S
    Radiother Oncol; 2014 Mar; 110(3):429-34. PubMed ID: 24630535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High b-Value Diffusion MRI to Differentiate Recurrent Tumors from Posttreatment Changes in Head and Neck Squamous Cell Carcinoma: A Single Center Prospective Study.
    Acampora A; Manzo G; Fenza G; Busto G; Serino A; Manto A
    Biomed Res Int; 2016; 2016():2865169. PubMed ID: 27376081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck squamous cell carcinoma.
    Noij DP; Pouwels PJW; Ljumanovic R; Knol DL; Doornaert P; de Bree R; Castelijns JA; de Graaf P
    Eur J Radiol; 2015 Jan; 84(1):108-116. PubMed ID: 25467228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Local Tumor Recurrence After Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Histogram Analysis of Dynamic Contrast-Enhanced T1-Weighted Perfusion MRI.
    Choi SH; Lee JH; Choi YJ; Park JE; Sung YS; Kim N; Baek JH
    AJR Am J Roentgenol; 2017 Jan; 208(1):42-47. PubMed ID: 27680294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC).
    Abdelaziz TT; Abdel Razk AAK; Ashour MMM; Abdelrahman AS
    Cancer Imaging; 2020 Aug; 20(1):61. PubMed ID: 32811559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.
    Ailianou A; Mundada P; De Perrot T; Pusztaszieri M; Poletti PA; Becker M
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):748-755. PubMed ID: 29449279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors.
    Varoquaux A; Rager O; Dulguerov P; Burkhardt K; Ailianou A; Becker M
    Radiographics; 2015; 35(5):1502-27. PubMed ID: 26252192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target Volume Delineation Based on Diffusion-weighted magnetic Resonance Imaging for Locally Advanced Head and Neck Cancer.
    DE Felice F; Musio D; Bulzonetti N; Maghella F; Tombolini V
    Anticancer Res; 2016 Aug; 36(8):4181-5. PubMed ID: 27466529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.